These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9488034

  • 1. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells.
    Lu Y, Yamagishi N, Yagi T, Takebe H.
    Oncogene; 1998 Feb 12; 16(6):705-12. PubMed ID: 9488034
    [Abstract] [Full Text] [Related]

  • 2. Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells.
    Lu Y, Tatsuka M, Takebe H, Yagi T.
    Mol Carcinog; 2000 Sep 12; 29(1):1-7. PubMed ID: 11020241
    [Abstract] [Full Text] [Related]

  • 3. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace AJ, O'Connor PM.
    Oncogene; 1996 Feb 01; 12(3):595-607. PubMed ID: 8637717
    [Abstract] [Full Text] [Related]

  • 4. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A.
    Oncogene; 1996 May 16; 12(10):2155-64. PubMed ID: 8668341
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 May 27; 18(21):3290-302. PubMed ID: 10359535
    [Abstract] [Full Text] [Related]

  • 6. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
    Sekiguchi T, Hunter T.
    Oncogene; 1998 Jan 22; 16(3):369-80. PubMed ID: 9467962
    [Abstract] [Full Text] [Related]

  • 7. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF, Faure R, Piedboeuf B, Mirault ME.
    Exp Cell Res; 2000 May 01; 256(2):347-57. PubMed ID: 10772807
    [Abstract] [Full Text] [Related]

  • 8. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May 01; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US, Park SK, Lee YI, Park JG, Lee YI.
    Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595
    [Abstract] [Full Text] [Related]

  • 10. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction.
    Prabhu NS, Blagosklonny MV, Zeng YX, Wu GS, Waldman T, El-Deiry WS.
    Clin Cancer Res; 1996 Jul 13; 2(7):1221-9. PubMed ID: 9816291
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J, Ammanamanchi S, Ko TC, Brattain MG.
    Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668
    [Abstract] [Full Text] [Related]

  • 12. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV.
    Oncogene; 1999 Oct 07; 18(41):5611-9. PubMed ID: 10523840
    [Abstract] [Full Text] [Related]

  • 13. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 Jul 29; 18(30):4313-25. PubMed ID: 10439039
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y, Jenkins CW, Nichols MA, Xiong Y.
    Oncogene; 1994 Aug 29; 9(8):2261-8. PubMed ID: 7913544
    [Abstract] [Full Text] [Related]

  • 15. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA.
    Oncogene; 1999 May 06; 18(18):2789-97. PubMed ID: 10362249
    [Abstract] [Full Text] [Related]

  • 16. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1.
    Mitsui K, Matsumoto A, Ohtsuka S, Ohtsubo M, Yoshimura A.
    Biochem Biophys Res Commun; 1999 Oct 22; 264(2):457-64. PubMed ID: 10529385
    [Abstract] [Full Text] [Related]

  • 17. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC, Chen YQ.
    Oncogene; 1998 Sep 24; 17(12):1549-56. PubMed ID: 9794232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y, Hurwitz J, Massagué J.
    Nature; 1995 May 11; 375(6527):159-61. PubMed ID: 7753174
    [Abstract] [Full Text] [Related]

  • 20. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
    Strasberg Rieber M, Welch DR, Miele ME, Rieber M.
    Cell Growth Differ; 1996 Feb 11; 7(2):197-202. PubMed ID: 8822203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.